GlucoTrack Inc. (GCTK)
NASDAQ: GCTK
· Real-Time Price · USD
0.15
0.01 (4.17%)
At close: Jun 09, 2025, 3:59 PM
Company Description
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally.
It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain.
The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021.
GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.
GlucoTrack Inc.
| Country | IL |
| IPO Date | Apr 25, 2013 |
| Industry | Medical - Instruments & Supplies |
| Sector | Healthcare |
| Employees | 11 |
| CEO | Paul V. Goode Ph.D. |
Contact Details
Address: 8 Ariel Sharon Street Or Yehuda, IL | |
| Website | https://www.glucotrack.com |
Stock Details
| Ticker Symbol | GCTK |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001506983 |
| CUSIP Number | 45824Q507 |
| ISIN Number | US45824Q5071 |
| Employer ID | 98-0668934 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Paul V. Goode Ph.D. | Chief Executive Officer, President & Director |
| Peter C. Wulff | Chief Financial Officer, Treasurer & Secretary |
| Avner Gal MBA, MSc.EE | Co-Founder, Chairman Emeritus, Consultant and Member of Scientific & Clinical Advisory Board |
| David Malka BA | Co-Founder |
| Drinda Benjamin | Vice President of Marketing |
| Mark Tapsak Ph.D. | Chief Scientific Officer |
| Vincent Wong | Vice President of Operations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 04, 2025 | 8-K | Current Report |
| May 23, 2025 | 8-K | Current Report |
| May 20, 2025 | 8-K | Current Report |
| May 14, 2025 | 10-Q | Quarterly Report |
| May 14, 2025 | 8-K | Current Report |
| May 13, 2025 | 8-K | Current Report |
| Apr 29, 2025 | 8-K | Current Report |
| Apr 28, 2025 | ARS | Filing |
| Apr 28, 2025 | DEF 14A | Filing |
| Apr 18, 2025 | PRE 14A | Filing |